U.S. Senator Robert Menendez (New Jersey) reintroduces the CARE for Tourette Syndrome Act.
The NJ Center for Tourette Syndrome and Associated Disorders, Inc. (NJCTS) is proud to announce the reintroduction of federal legislation for Tourette Syndrome by U.S. Senator Robert Menendez (New Jersey).
Titled the Collaborative Academic Research Efforts (CARE) for Tourette Syndrome Act of 2017, the legislation would amend the Public Health Service Act to provide for the expansion, intensification, and coordination of the programs and activities of the National Institutes of Health (NIH) with respect to Tourette Syndrome.
“With tens of thousands of our children and teens afflicted with Tourette Syndrome, this debilitating disorder deserves greater attention from our nation’s scientific research institutions,” said Senator Menendez. “We must do everything we can to develop effective treatments and a cure for TS to help ease the suffering and help unlock every child’s full potential.”
NJ Center for Tourette Syndrome and Associated Disorders, the nation’s first center of excellence for TS, was established in 2004. Senator Menendez worked closely with Executive Director Faith Rice and NJCTS leadership to craft this legislation in 2011.
“New Jersey has changed the face of TS research, education, and support through partnerships and collaborations,” says Rice. “We are delighted that Senator Menendez continues to support this ground-breaking legislation in support of the 1 in 100 Americans living with this misunderstood neurological disorder.”
A primary purpose of this legislation is to establish regional centers of excellence across the country to conduct research into the cause, diagnosis, early detection, prevention, control and treatment of Tourette Syndrome and associated disorders.
For more information about Tourette Syndrome and NJCTS, contact 908-575-7350 or visit www.njcts.org.